Clearance of NNAL and Cotinine From Second-hand Smoke in Hair and Urine
NCT00863824 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-08-14
Summary
This study will investigate how long it takes for NNAL and cotinine, markers of second hand smoke, to clear the human body.
Conditions
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
University of Nebraska
lead OTHER
Principal Investigators
-
Chandran Achuatn, PhD · University of Nebraska
Eligibility
- Min Age
- 19 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-05-11
- Completion
- 2010-05-11
More Related Trials
-
DNA Repair and Genetic Susceptibility to Lung Cancer
NCT00611598 ·Status: COMPLETED
-
Genetic Susceptibility to Bladder Cancer
NCT00848289 ·Status: ACTIVE_NOT_RECRUITING
-
Hair Isotope Analysis for Early Cancer Detection
NCT07006909 ·Status: NOT_YET_RECRUITING
-
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
NCT00318604 ·Status: UNKNOWN
-
A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
NCT01063998 ·Status: TERMINATED
-
DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
NCT00339859 ·Status: COMPLETED
-
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT04099290 ·Status: RECRUITING
-
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
NCT02441140 ·Status: TERMINATED ·Phase: NA
-
Biomarker Identification for Bladder Cancer Patients
NCT02053662 ·Status: TERMINATED
-
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT05366881 ·Status: RECRUITING
-
Cell-free DNA in Hereditary And High-Risk Malignancies 1
NCT04261972 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
NCT03071809 ·Status: TERMINATED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
NCT03947346 ·Status: COMPLETED
-
Circulating DNA in Surgically Treated NSCLC
NCT04037150 ·Status: UNKNOWN
-
Biomarkers in Patients With Head and Neck Cancer
NCT01466257 ·Status: COMPLETED
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer
NCT05574738 ·Status: RECRUITING
-
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
NCT02245100 ·Status: COMPLETED
-
Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients
NCT02186236 ·Status: COMPLETED
-
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
NCT02853097 ·Status: TERMINATED
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450448 ·Status: COMPLETED
-
ctDNA for Early Detection of Recurrence in Melanoma
NCT06246227 ·Status: ACTIVE_NOT_RECRUITING
-
CfDNA in Hereditary And High-risk Malignancies 2
NCT06726642 ·Status: RECRUITING